Two Sigma Securities’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Two Sigma Securities’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-15,539	Closed	-$193K	–	1249
2016 Q4	$193K	Sell	15,539 -25,069	-62%	-$302K	0.06%	468
2016 Q3	$556K	Buy	+40,608	New	+$408K	0.19%	140
2016 Q2	–	Sell	-10,328	Closed	-$66K	–	581
2016 Q1	$66K	Sell	10,328 -1,232	-11%	-$6.91K	0.08%	189
2015 Q4	$72K	Buy	+11,560	New	+$75.9K	0.09%	174

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Two Sigma Securities's ARIA Position: Q1 2017 in Review

Two Sigma Securities sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 15,539 shares — an estimated $193K sold.

Two Sigma Securities first reported a position in ARIA in Q4 2015 and held it in 4 quarters. The position peaked at $556K in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Two Sigma Securities reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Two Sigma Securities sold 15,539 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $193K.
Two Sigma Securities first reported a position in Ariad Pharmaceuticals Inc in Q4 2015 and held it in 4 quarters.
Two Sigma Securities's Ariad Pharmaceuticals Inc position peaked at $556K in Q3 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Two Sigma Securities's 13F filing for Q1 2017, filed 15 May 2017.